Intercept Pharma (ICPT) Chief Medical Officer Jason Campagna Resigns to Pursue Other Opportunities

February 22, 2021 4:53 PM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Intercept Pharma (NASDAQ: ICPT) disclosed:

On February 18, 2021, Jason Campagna, M.D., Ph.D., notified Intercept Pharmaceuticals, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Medical Officer, effective March 5, 2021, in order to pursue other opportunities. Dr. Campagna’s resignation was not the result of any disagreement regarding any matter related to the Company’s operations, policies, or practices.

Gail Cawkwell will serve as acting Chief Medical Officer pending appointment of a permanent replacement.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes